Global Health
From Lab to Field: Progress in Crimean-Congo Haemorrhagic Fever Testing
In the ongoing fight against Crimean-Congo Haemorrhagic Fever (CCHF), Global Access Diagnostics (GADx) has joined forces with the Liverpool School of Tropical Medicine and international experts to develop a…
Rapid Diagnostics for a Better World – POCT Leipzig Insights
Dr. Kevin Land, the Head of Innovative Research and Development at Global Access Diagnostics (GADx), delivered a compelling keynote at the prestigious POCT Leipzig conference on April 17, 2024.…
Innovating Epidemic Surveillance: GADx partners on HOLICARE
GADx, in partnership with an international consortium, is revolutionising healthcare in low- and middle-income countries through the HOLICARE project. HOLICARE is a groundbreaking initiative established to improve the diagnosis…
GADx acquires manufacturing rights for IT LEISH rapid diagnostic test from Bio-Rad Laboratories
Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics and driving local manufacturing, today announced it has acquired the manufacturing rights for the IT LEISH rapid…
Mologic to become a ‘Social Enterprise’ after acquisition by social impact funders and investors
A group of philanthropic funds and investors led by the Soros Economic Development Fund (SEDF), with support from the Bill & Melinda Gates Foundation, is today announcing the launch…